BIOTECH ACQUISITION COMPANY's ticker is BIOT and the CUSIP is G1125A108. A total of 77 filers reported holding BIOTECH ACQUISITION COMPANY in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $2,494,751 | +1.7% | 247,005 | 0.0% | 0.04% | -2.4% |
Q3 2022 | $2,452,000 | +0.3% | 247,005 | 0.0% | 0.04% | +17.1% |
Q2 2022 | $2,445,000 | +0.5% | 247,005 | 0.0% | 0.04% | +12.9% |
Q1 2022 | $2,433,000 | +336.8% | 247,005 | +336.2% | 0.03% | +342.9% |
Q4 2021 | $557,000 | – | 56,628 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RiverPark Advisors, LLC | 799,001 | $7,930,000 | 2.58% |
Corbin Capital Partners, L.P. | 928,124 | $9,207,000 | 2.29% |
Cohanzick Management, LLC | 799,001 | $7,926,000 | 1.92% |
RPO LLC | 379,021 | $3,762,000 | 0.91% |
Arena Capital Advisors, LLC- CA | 300,000 | $2,978,000 | 0.90% |
Alpha Wave Global, LP | 532,570 | $5,286,000 | 0.62% |
MIZUHO SECURITIES USA LLC | 444,957 | $4,383,000 | 0.60% |
MMCAP International Inc. SPC | 599,321 | $5,945,000 | 0.47% |
GLAZER CAPITAL, LLC | 2,285,000 | $22,667,000 | 0.42% |
CVI Holdings, LLC | 292,563 | $2,904,000 | 0.22% |